JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.

Medical Molecular Morphology, published by SPRINGER JAPAN KK, stands as a significant resource in the fields of medicine and molecular biology, bridging critical insights between histological studies and modern therapeutic approaches. With an ISSN of 1860-1480 and E-ISSN of 1860-1499, this journal has evolved since its inception in 1996 and has continued to provide a platform for innovative research through 2024, establishing its relevance particularly in the realms of medical pathology and molecular morphology. Although categorized as Q3 in Medicine (miscellaneous) and Q4 in Molecular Biology per the 2023 quartiles, the journal's unique contributions cannot be understated, as evidenced by its Scopus rankings, which place it in the 52nd percentile for Pathology and 19th percentile for Molecular Biology. The journal’s mission focuses on disseminating valuable findings that enhance the understanding of cellular and molecular structures and their implications in health and disease. As access options are not currently open access, it remains essential for professionals and researchers to consider the journal's contributions as they pursue academic growth and impactful research in these dynamic fields.

BRAIN PATHOLOGY, published by WILEY, is a leading journal in the fields of neurology, neuroscience, and pathology, recognized for its rigorous peer-review process and high-impact research contributions. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories, BRAIN PATHOLOGY maintains a prominent status, with a Scopus ranking placing it among the top 10% of journals in its fields. Since its inception in 1990, the journal has served as a crucial platform for researchers and clinicians alike, disseminating groundbreaking findings that advance our understanding of brain diseases and injuries. Through its dedication to publishing high-quality, innovative research, BRAIN PATHOLOGY plays a vital role in shaping the future of brain pathology research. While it does not currently offer open access, articles can be accessed through institutional subscriptions. Researchers, professionals, and students are encouraged to contribute to and engage with this esteemed publication to foster knowledge and collaboration within this dynamic field.

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

ADVANCES IN ANATOMIC PATHOLOGY is a leading peer-reviewed journal dedicated to the field of anatomical pathology, published by LIPPINCOTT WILLIAMS & WILKINS. With an impressive impact factor and consistent ranking in the Q1 category for both Anatomy and Pathology and Forensic Medicine, it serves as an essential resource for researchers, clinicians, and students alike. The journal has been a critical platform for disseminating significant findings and advancements in the discipline since its inception in 1996, boasting Scopus rankings of #1 in Anatomy and #11 in Pathology. While it does not provide open access, it maintains rigorous standards in the selection of articles, ensuring that published research reflects the latest developments and techniques in the field. As we look toward 2024 and beyond, ADVANCES IN ANATOMIC PATHOLOGY remains committed to advancing the science of pathology, fostering innovation, and enhancing clinical practice through impactful research.

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.

Seminars in Diagnostic Pathology is a premier journal that has established itself as an essential resource in the field of pathology since its inception in 1984. Published by W B Saunders Co-Elsevier Inc, this journal boasts an impressive Q1 ranking in the pathology category for 2023, placing it in the top tier of medical journals worldwide. With a focus on diagnostic pathology, it offers a platform for groundbreaking research and advancements that bridge the gap between basic science and clinical practice. The journal is committed to publishing high-quality review articles, case reports, and expert opinions that provide valuable insights for professionals, researchers, and students alike. Although it operates on a subscription model, the journal's extensive impact is reflected in its Scopus rank (#56/208), with a remarkable 73rd percentile standing in the pathology and forensic medicine category. The journal's authoritative content not only aids in enhancing knowledge but also fosters an understanding of the evolving challenges and methodologies in diagnostic pathology, making it an indispensable tool for anyone dedicated to excellence in the field.

FOLIA NEUROPATHOLOGICA is a distinguished Open Access journal specializing in the fields of Neurology and Pathology, published by the reputable TERMEDIA PUBLISHING HOUSE LTD. With an ISSN of 1641-4640 and E-ISSN 1509-572X, this journal has been a vital resource for the dissemination of high-quality research since its inception in 1994. Covering a broad spectrum of topics within neuropathology, the journal emphasizes clinical findings and forensic implications, making it an essential platform for healthcare professionals, researchers, and students alike. With impressive impact factors positioning it in the Q3 category for both Neurology (clinical) and Pathology and Forensic Medicine, FOLIA NEUROPATHOLOGICA occupies a significant place among its peers, ranked within the 36th to 46th percentiles on Scopus. Scholars can benefit from the Open Access model implemented since 2005, ensuring wide accessibility and distribution of critical research outputs aimed at advancing both clinical practices and academic knowledge. Based in Poland, at KLEEBERGA 2, POZNAN 61-615, this journal continues to shape the discourse in neuropathology and related fields.

AMERICAN JOURNAL OF DERMATOPATHOLOGY, published by Lippincott Williams & Wilkins, is an essential resource for professionals and researchers engaged in the fields of dermatology, pathology, and forensic medicine. Established in 1979, the journal aims to disseminate cutting-edge research and advancements pertaining to the microscopic examination of skin disorders. With an esteemed impact factor that positions it well within the Q3 category of dermatology and pathology as of 2023, the journal ranks #81 out of 142 in dermatology and #130 out of 208 in pathology according to Scopus. Although it does not currently offer open access options, the journal provides valuable insights and substantial contributions to the understanding of dermatopathology, making it a vital tool for academics, clinicians, and students seeking to stay abreast of the latest findings and practices in the field. Its commitment to high-quality research continues to foster a deeper understanding of skin diseases, enhancing patient care and scientific inquiry alike.